Evidence map›Paper›PMID 25390639›Full record

ArticlePloS one2014

Molecular epidemiology of seal parvovirus, 1988-2014.

Rogier Bodewes, Rebriarina Hapsari, Ana Rubio García, Guillermo J Sánchez Contreras, Marco W G van de Bildt, Miranda de Graaf, Thijs Kuiken, Albert D M E Osterhaus

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Evolution and phylogeography ofVirus evolution · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Rogier BodewesDepartment of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
Rebriarina HapsariDepartment of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
Ana Rubio GarcíaSeal Rehabilitation and Research Centre, Pieterburen, the Netherlands.
Guillermo J Sánchez ContrerasSeal Rehabilitation and Research Centre, Pieterburen, the Netherlands.
Marco W G van de BildtDepartment of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
Miranda de GraafDepartment of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
Thijs KuikenDepartment of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
Albert D M E OsterhausDepartment of Viroscience, Erasmus MC, Rotterdam, the Netherlands; Viroclinics Biosciences BV, Rotterdam, the Netherlands; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine, Hannover, Germany; Artemis One Health, Utrecht, the Netherlands.
Erasmus University Rotterdam · NLErasmus MC · NLUniversity of Veterinary Medicine Hannover, Foundation · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel parvovirus was discovered recently in the brain of a harbor seal (Phoca vitulina) with chronic meningo-encephalitis. Phylogenetic analysis of this virus indicated that it belongs to the genus Erythroparvovirus, to which also human parvovirus B19 belongs. In the present study, the prevalence, genetic diversity and clinical relevance of seal parvovirus (SePV) infections was evaluated in both harbor and grey seals (Halichoerus grypus) that lived in Northwestern European coastal waters from 1988 to 2014. To this end, serum and tissue samples collected from seals were tested for the presence of seal parvovirus DNA by real-time PCR and the sequences of the partial NS gene and the complete VP2 gene of positive samples were determined. Seal parvovirus DNA was detected in nine (8%) of the spleen tissues tested and in one (0.5%) of the serum samples tested, including samples collected from seals that died in 1988. Sequence analysis of the partial NS and complete VP2 genes of nine SePV revealed multiple sites with nucleotide substitutions but only one amino acid change in the VP2 gene. Estimated nucleotide substitution rates per year were 2.00 × 10(-4) for the partial NS gene and 1.15 × 10(-4) for the complete VP2 gene. Most samples containing SePV DNA were co-infected with phocine herpesvirus 1 or PDV, so no conclusions could be drawn about the clinical impact of SePV infection alone. The present study is one of the few in which the mutation rates of parvoviruses were evaluated over a period of more than 20 years, especially in a wildlife population, providing additional insights into the genetic diversity of parvoviruses.

Indexed as

AnimalsAtlantic OceanBase SequenceBrainCapsid ProteinsDNA, ViralEuropeGenome, ViralMeningoencephalitisMolecular EpidemiologyParvovirusPhocaPhylogenyPrevalenceReal-Time Polymerase Chain ReactionSequence Analysis, DNACapsid ProteinsDNA, ViralViral Nonstructural ProteinsVP2 protein, Poliovirus

Identifiers

PMID25390639
PMCPMC4229121
OpenAlexW2325918847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.